Web
DirectoryNeuroGeneration: Neural Stem Cell Therapies Biotechnology for Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS
NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
October 29-30,2007
7th International Stem Cell Meeting.Oct 29-30,2007.Pittsburgh. NeuroGeneration will present... more>
May 7,2007
NeuroGeneration selected to participate at the gene/cell therapy session of the BIO 2007 International Convention in Boston..more>
February 12. 2007
NeuroGeneration's CEO, Michel Levesque, M.D., will be a guest speaker at the International Stem Cell...more>
NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.
